Key Highlights

● Second-quarter revenue rose 9.1 per cent year over year to $1.43 billion.

● Net income rose 49.8 per cent year over year to $76.3 million.

● Skilled nursing occupancy reached 90.4 per cent, above the company's cited industry average.

● Full-year 2026 adjusted EBITDA guidance was raised to $640 million to $660 million.

PACS Group (NYSE:PACS) is a holding company focused on post-acute healthcare, founded in 2013. Its subsidiaries operate 344 facilities across 17 states and serve more than 33,400 patients daily. On 4 August 2026 it reported second-quarter revenue of $1.43 billion, up 9.1 per cent, and net income of $76.3 million, up 49.8 per cent from $51.0 million. Diluted earnings per share were $0.47, and adjusted earnings per share were $0.63, up 34.0 per cent. Adjusted EBITDA rose 24.6 per cent to $166.8 million, with adjusted EBITDAR of $261.5 million.

Operations, guidance and cash

Skilled nursing facilities recorded 2,697,638 patient days across 290 facilities, with occupancy of 90.4 per cent against what the company cites as an industry average of 79.5 per cent. Skilled mix was 30.0 per cent of patient days, and 83.6 per cent of skilled nursing facilities carried four or five CMS stars. Management raised full-year 2026 guidance, to adjusted EBITDA of $640 million to $660 million from $605 million to $625 million, and revenue of $5.75 billion to $5.85 billion from $5.65 billion to $5.75 billion. The guidance includes 20 Texas facilities from the Eduro acquisition that closed on 1 August 2026 but excludes the remaining Eduro facilities and future deals. Chief executive Jason Murray said the results reflect the continued strength of the platform. Those are company projections, not certainties. Same-store occupancy improved to 90.6 per cent from 89.1 per cent, and mature facilities reached 93.8 per cent. Chief financial officer Carey Hendrickson said the company was increasing its full-year adjusted EBITDA range.

Balance sheet and the unresolved issues

At 30 June 2026 cash was $164.5 million and total liquidity $756.6 million. Operating cash flow for the six months was $371.8 million. Long-term debt was $238.7 million plus $7.4 million current, and the line of credit was undrawn, against $100.0 million at the end of 2025. Operating lease liabilities, however, total about $3.0 billion, which matters when comparing leverage with owner-operators. Refund liabilities stood at $181.1 million and accrued self-insurance liabilities at roughly $395 million. Legal and other costs were $8.2 million, down from $24.1 million, and relate to the Audit Committee investigation conducted across 2024 and 2025 and other ongoing investigations. The release refers readers to risk factors in the 2025 Form 10-K, including internal control material weaknesses, and flags uncertainty over California WQIP payments. The company does not pay a dividend in the sources reviewed. Real estate investment was $104.3 million in the quarter and $190.8 million for the year to date. The portfolio includes 64 owned facilities and 49 leased facilities with partial real estate ownership, plus purchase options on 36 leased facilities. Eduro adds 3,633 beds, with the remaining 14 Eduro facilities expected to close in the third and fourth quarters of 2026.

Integration and Legacy Investigations Remain Open Items

PACS Group's occupancy and skilled-mix metrics point to a well-run portfolio, and the Eduro acquisition is already adding facilities and beds to the network, with 14 more locations expected to close later in 2026. Operating lease liabilities of about $3.0 billion are a significant factor when comparing leverage with owner-operators, and legal costs tied to an Audit Committee investigation conducted across 2024 and 2025, alongside other ongoing investigations, remain a factor for investors to track even as those costs have fallen sharply from a year earlier.